Safety and Efficacy Study of Transdermal Oxybutynin to Treat Overactive Bladder With a Neurological Condition
Public ClinicalTrials.gov record NCT00224016. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Multi-Center, Open-Label (OL), Active-Controlled, Dose-Titration Study Evaluating the Safety, Efficacy and PK of Oxybutynin Transdermal Systems in the Treatment of Detrusor Overactivity in Pediatric Patients
Study identification
- NCT ID
- NCT00224016
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 4
- Lead sponsor
- Watson Pharmaceuticals
- Industry
- Enrollment
- 57 participants
Conditions and interventions
Conditions
Interventions
- Oxybutynin Drug
Drug
Eligibility (public fields only)
- Age range
- 6 Years to 15 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Nov 30, 2004
- Primary completion
- Mar 31, 2007
- Completion
- Aug 31, 2008
- Last update posted
- Feb 8, 2012
2004 – 2008
United States locations
- U.S. sites
- 23
- U.S. states
- 16
- U.S. cities
- 23
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Watson Investigational Site | Little Rock | Arkansas | — | — |
| Watson Investigational Site | Orange County | California | — | — |
| Watson Investigational Site | San Diego | California | — | — |
| Watson Investigational Site | Denver | Colorado | — | — |
| Watson Investigational Site | Washington D.C. | District of Columbia | — | — |
| Watson Investigational Site | Detroit | Michigan | — | — |
| Watson Investigational Site | Minneapolis | Minnesota | — | — |
| Watson Investigational Site | Jackson | Mississippi | — | — |
| Watson Investigational Site | Kansas City | Missouri | — | — |
| Watson Investigational Site | St Louis | Missouri | — | — |
| Watson Investigational Site | Voorhees Township | New Jersey | — | — |
| Watson Investigational Site | Albany | New York | — | — |
| Watson Investigational Site | Buffalo | New York | — | — |
| Watson Investigational Site | Poughkeepsie | New York | — | — |
| Watson Investigational Site | Ashville | North Carolina | — | — |
| Watson Investigational Site | Durham | North Carolina | — | — |
| Watson Investigational Site | Columbus | Ohio | — | — |
| Watson Investigational Site | Oklahoma City | Oklahoma | — | — |
| Watson Investigational Site | Hershy | Pennsylvania | — | — |
| Watson Investigational Site | Dallas | Texas | — | — |
| Watson Investigational Site | Houston | Texas | — | — |
| Watson Investigational Site | Plano | Texas | — | — |
| Watson Investigational Site | Salt Lake City | Utah | — | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00224016, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Feb 8, 2012 · Synced Jul 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00224016 live on ClinicalTrials.gov.